Outcome of 12-Weeks Triple Therapy (TT), Including Sofosbuvir (SOF), Ribavirin and Pegylated Interferon-Alfa in All Non-Cirrhotic Patients With Chronic Hepatitis-C Genotype-3 Infection. mfm 2024, 28 (7).